In this issue:
Adverse pregnancy outcomes in axSpA
Effectiveness and safety of tofacitinib for SpA
Frailty and associating factors for axSpA patients
Joint shape variations associated with increased risks for axSpA
Influenza AEs in tofacitinib treated RA, UC and PsA patients
Ustekinumab versus TNFi in PsA
Efficacy and safety of guselkumab in active PsA
Performance tests in axSpA patients
Women with PsA having a decreased QOL
Sex-based differences in PsA
Please login below to download this issue (PDF)